<!-- # COPYRIGHT NOTICE # This file is part of the "Universal Biomedical Skills" project. # Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu> # All Rights Reserved. # # This code is proprietary and confidential. # Unauthorized copying of this file, via any medium is strictly prohibited. # # Provenance: Authenticated by MD BABU MIA -->

---

name: 'time-resolved-cryoem-agent' description: 'AI-powered time-resolved cryo-EM analysis for capturing protein dynamics, drug-binding kinetics, and conformational transitions for dynamics-based drug discovery.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:

• read_file
• run_shell_command

---

Time-Resolved Cryo-EM Agent

The Time-Resolved Cryo-EM Agent leverages time-resolved cryo-electron microscopy to capture protein dynamics, drug-binding kinetics, and conformational transitions. It integrates AI-powered analysis with experimental time-resolved data to enable dynamics-based drug discovery, moving beyond static structures to understand drug mechanisms in motion.

When to Use This Skill

• When studying drug-binding kinetics structurally.
• For capturing protein conformational transitions.
• To understand allosteric mechanisms and dynamics.
• When designing drugs targeting specific conformational states.
• For characterizing enzyme catalytic cycles.

Core Capabilities

1. Kinetics Extraction: Extract binding kinetics from time-resolved data.

2. Conformational Sorting: Classify particles by conformational state.

3. Trajectory Reconstruction: Build conformational trajectories.

4. Intermediate Identification: Detect rare intermediate states.

5. MD Integration: Combine with molecular dynamics simulations.

6. Dynamics-Based Design: Design drugs targeting specific states.

Time-Resolved Methods

Method	Timescale	Resolution	Application
Rapid Mixing	ms-s	3-4 Å	Ligand binding
Temperature Jump	μs-ms	3-5 Å	Transitions
Photocaging	μs-ms	3-5 Å	Triggered reactions
Flow-Mixing	10ms-s	3-4 Å	Enzyme kinetics

Workflow

1. Input: Time-resolved cryo-EM datasets, protein sequence.

2. Particle Processing: 3D classification across timepoints.

3. State Assignment: AI-powered conformational sorting.

4. Kinetics Fitting: Extract rate constants.

5. Intermediate Mapping: Identify transient states.

6. Drug Design: Target state-specific pockets.

7. Output: Kinetic models, conformational movie, design targets.

Example Usage

User: "Analyze time-resolved cryo-EM data of this kinase to understand drug binding kinetics and identify targetable intermediate states."

Agent Action:

python3 Skills/Structural_Biology/Time_Resolved_CryoEM_Agent/analyze_dynamics.py \
    --timepoints "0ms,10ms,50ms,100ms,500ms,1s" \
    --particle_stacks timepoint_particles/ \
    --protein_sequence kinase.fasta \
    --ligand drug_compound.sdf \
    --kinetics_model two_state \
    --extract_intermediates true \
    --output kinase_dynamics/

Input Requirements

Input	Format	Purpose
Particle Stacks	MRC per timepoint	Time-resolved data
Timepoint Labels	CSV	Time assignments
Protein Sequence	FASTA	Structure reference
Ligand Structure	SDF	Binding analysis
Initial Model	Optional PDB	3D classification

Output Components

Output	Description	Format
Conformational States	Per-timepoint structures	.pdb
Kinetics Parameters	kon, koff, Kd	.json
State Populations	Fraction vs time	.csv
Conformational Movie	Trajectory animation	.mp4
Intermediate Structures	Transient states	.pdb
Energy Landscape	Free energy surface	.png
Drug Design Targets	State-specific pockets	.json

Kinetics Analysis

Parameter	Definition	Drug Design Relevance
kon	Association rate	Target engagement speed
koff	Dissociation rate	Residence time
Kd	Equilibrium constant	Affinity
t1/2	Half-life	Duration of action
Conformational Rate	State transition speed	Mechanism insight

AI/ML Components

Conformational Sorting:

• 3D variational autoencoders
• Heterogeneous reconstruction
• Continuous conformational analysis (cryoDRGN)

Kinetics Modeling:

• Hidden Markov models
• Bayesian kinetics fitting
• Deep learning rate estimation

Intermediate Detection:

• Rare event identification
• Manifold learning
• Transition path sampling

Drug Discovery Applications

Application	Dynamic Insight	Design Strategy
Slow Binding	Long residence time	Optimize koff
Allosteric Drugs	State stabilization	Target intermediate
Covalent Inhibitors	Binding trajectory	Optimize approach
Conformational Selection	State preference	Pre-organize ligand
Induced Fit	Protein reorganization	Accommodate flexibility

Prerequisites

• Python 3.10+
• cryoSPARC, RELION
• cryoDRGN
• GROMACS/OpenMM
• PyTorch

Related Skills

• CryoEM_AI_Drug_Design_Agent - Static structure design
• Molecular_Dynamics_Agent - MD simulations
• AlphaFold3_Agent - Structure prediction
• PROTAC_Design_Agent - Degrader design

Conformational Analysis Methods

Method	Software	Best For
3DVA	cryoSPARC	Principal motions
Multi-body	RELION	Domain movements
cryoDRGN	cryoDRGN	Continuous heterogeneity
3D Classification	Various	Discrete states

Time Resolution Capabilities

Mixing Method	Dead Time	Applications
Rapid On-Grid	~10 ms	Fast binding
Blot-Free	~1 ms	Very fast kinetics
Microfluidic	~50 ms	Enzyme catalysis
Spray-Mixing	~10 ms	Protein-protein

Special Considerations

1. Sample Consumption: Time-resolved requires more sample
2. Synchronization: Initiation must be well-controlled
3. Resolution Trade-off: Fewer particles per timepoint
4. Intermediate Lifetime: Must match experimental timescale
5. Data Quality: Requires high-quality data collection

Kinetic Mechanisms

Mechanism	Model	Parameters
Two-State	A ⇌ B	kon, koff
Induced Fit	A + L ⇌ AL ⇌ AL*	Multiple rates
Conformational Selection	A ⇌ A* + L ⇌ A*L	Pre-equilibrium
Sequential	A → B → C	Multiple intermediates

Validation Approaches

Method	Purpose	Complementarity
SPR	Binding kinetics	Validate rates
ITC	Thermodynamics	Validate ΔG
NMR	Dynamics	Solution behavior
MD Simulation	Mechanism	Molecular detail

Applications in Drug Discovery

Target	Dynamic Insight	Design Implication
Kinases	DFG-in/out transition	State-selective inhibitors
GPCRs	Activation pathway	Biased agonists
Transporters	Alternating access	Mechanism-based design
ATPases	Catalytic cycle	Allosteric inhibitors

Author

AI Group - Biomedical AI Platform

<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->